Treace John T. - 10 Jan 2026 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Lisa Taylor as Attorney-in-fact for John Treace
Issuer symbol
TMCI
Transactions as of
10 Jan 2026
Net transactions value
$0
Form type
4
Filing time
13 Jan 2026, 21:30:03 UTC
Previous filing
11 Mar 2025
Next filing
23 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Treace John T. Chief Executive Officer, Director, 10%+ Owner C/O TREACE MEDICAL CONCEPTS, INC., 100 PALMETTO PARK PLACE, PONTE VEDRA /s/ Lisa Taylor as Attorney-in-fact for John Treace 13 Jan 2026 0001856380

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMCI Common Stock Tax liability $0 -13,219 -0.19% $0.000000 6,775,887 10 Jan 2026 Direct F1
holding TMCI Common Stock 1,605,000 10 Jan 2026 By spouse F2
holding TMCI Common Stock 1,471,250 10 Jan 2026 by spouse as trustee of a trust F2
holding TMCI Common Stock 1,839,063 10 Jan 2026 As trustee of a trust F3
holding TMCI Common Stock 408,816 10 Jan 2026 As co-trustee of a trust F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 363,867 restricted stock units.
F2 The Reporting Person disclaims beneficial ownershup of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee.
F3 The Reporting Person disclaims beneficial ownership of shares held in trust for which he serves as trustee or co-trustee.